blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3675960

EP3675960 - COMPOSITION FOR USE OF SAME IN THE TREATMENT AND/OR PREVENTION OF INFERTILITY [Right-click to bookmark this link]
StatusThe patent has been granted
Status updated on  23.02.2024
Database last updated on 13.11.2024
FormerGrant of patent is intended
Status updated on  02.01.2024
FormerExamination is in progress
Status updated on  13.10.2022
FormerRequest for examination was made
Status updated on  05.06.2020
FormerThe international publication has been made
Status updated on  08.03.2019
Formerunknown
Status updated on  03.09.2018
Most recent event   Tooltip01.11.2024Lapse of the patent in a contracting state
New state(s): PL, RO, SK
published on 04.12.2024 [2024/49]
Applicant(s)For all designated states
AXEEN PHARMA S.A.R.L.
5, rue du Gabian
Immeuble "Le Triton"
Bloc B - 2ème étage
98000 Monaco / MC
[2022/52]
Former [2020/28]For all designated states
Sérélys Pharma S.A.M.
5 Rue du Gabian
98000 Monaco / MC
Inventor(s)01 / MORRA, Sossio
4 avenue des Ligures
98000 Monaco / MC
 [2020/28]
Representative(s)Axe PI
7, place Ile de Beauté
06300 Nice / FR
[2020/28]
Application number, filing date18758631.827.08.2018
[2020/28]
WO2018EP73018
Priority number, dateFR2017007089428.08.2017         Original published format: FR 1770894
[2020/28]
Filing languageFR
Procedural languageFR
PublicationType: A1 Application with search report
No.:WO2019042934
Date:07.03.2019
Language:FR
[2019/10]
Type: A1 Application with search report 
No.:EP3675960
Date:08.07.2020
Language:FR
The application published by WIPO in one of the EPO official languages on 07.03.2019 takes the place of the publication of the European patent application.
[2020/28]
Type: B1 Patent specification 
No.:EP3675960
Date:27.03.2024
Language:FR
[2024/13]
Search report(s)International search report - published on:EP07.03.2019
ClassificationIPC:A61K36/15, A61K36/899, A61K31/355, A61P15/08, A61K31/122, A61K45/06
[2024/02]
CPC:
A61P15/08 (EP,US); A61K36/15 (EP,US); A61K31/01 (US);
A61K31/122 (EP,US); A61K31/197 (US); A61K31/355 (US);
A61K31/375 (US); A61K31/4415 (US); A61K31/525 (US);
A61K31/593 (US); A61K31/714 (US); A61K33/04 (US);
A61K33/30 (US); A61K36/31 (US); A61K36/899 (EP,US);
A61K45/06 (EP); A61K9/0053 (US); A61K9/2054 (EP);
A61K9/4866 (EP) (-)
C-Set:
A61K31/122, A61K2300/00 (EP);
A61K36/15, A61K2300/00 (EP);
A61K36/899, A61K2300/00 (EP)
Former IPC [2020/28]A61P15/08, A61K36/15, A61K36/899, A61K31/355
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2020/28]
Extension statesBANot yet paid
MENot yet paid
Validation statesKHNot yet paid
MANot yet paid
MDNot yet paid
TNNot yet paid
TitleGerman:ZUSAMMENSETZUNG ZUR VERWENDUNG BEI DER BEHANDLUNG UND / ODER PRÄVENTION VON UNFRUCHTBARKEIT[2020/28]
English:COMPOSITION FOR USE OF SAME IN THE TREATMENT AND/OR PREVENTION OF INFERTILITY[2020/28]
French:COMPOSITION POUR SON UTILISATION DANS LE TRAITEMENT ET/OU LA PREVENTION DE L'INFERTILITE[2020/28]
Entry into regional phase02.03.2020National basic fee paid 
02.03.2020Designation fee(s) paid 
02.03.2020Examination fee paid 
Examination procedure02.03.2020Examination requested  [2020/28]
02.03.2020Date on which the examining division has become responsible
30.09.2020Amendment by applicant (claims and/or description)
12.10.2022Despatch of a communication from the examining division (Time limit: M06)
14.02.2023Reply to a communication from the examining division
01.12.2023Cancellation of oral proceeding that was planned for 07.12.2023
07.12.2023Date of oral proceedings (cancelled)
03.01.2024Communication of intention to grant the patent
20.02.2024Fee for grant paid
20.02.2024Fee for publishing/printing paid
20.02.2024Receipt of the translation of the claim(s)
Fees paidRenewal fee
02.03.2020Renewal fee patent year 03
30.07.2021Renewal fee patent year 04
08.07.2022Renewal fee patent year 05
29.08.2023Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT27.03.2024
BG27.03.2024
CZ27.03.2024
EE27.03.2024
FI27.03.2024
HR27.03.2024
LT27.03.2024
LV27.03.2024
PL27.03.2024
RO27.03.2024
SE27.03.2024
SK27.03.2024
SM27.03.2024
NO27.06.2024
RS27.06.2024
GR28.06.2024
IS27.07.2024
PT29.07.2024
[2024/49]
Former [2024/48]AT27.03.2024
BG27.03.2024
CZ27.03.2024
EE27.03.2024
FI27.03.2024
HR27.03.2024
LT27.03.2024
LV27.03.2024
SE27.03.2024
SM27.03.2024
NO27.06.2024
RS27.06.2024
GR28.06.2024
IS27.07.2024
PT29.07.2024
Former [2024/47]BG27.03.2024
FI27.03.2024
HR27.03.2024
LT27.03.2024
LV27.03.2024
SE27.03.2024
SM27.03.2024
NO27.06.2024
RS27.06.2024
GR28.06.2024
IS27.07.2024
PT29.07.2024
Former [2024/46]BG27.03.2024
FI27.03.2024
HR27.03.2024
LT27.03.2024
LV27.03.2024
SE27.03.2024
NO27.06.2024
RS27.06.2024
GR28.06.2024
IS27.07.2024
Former [2024/37]BG27.03.2024
FI27.03.2024
HR27.03.2024
LT27.03.2024
LV27.03.2024
SE27.03.2024
NO27.06.2024
RS27.06.2024
GR28.06.2024
Former [2024/36]BG27.03.2024
FI27.03.2024
HR27.03.2024
LT27.03.2024
LV27.03.2024
NO27.06.2024
RS27.06.2024
GR28.06.2024
Former [2024/34]BG27.03.2024
FI27.03.2024
HR27.03.2024
LT27.03.2024
NO27.06.2024
RS27.06.2024
GR28.06.2024
Former [2024/33]LT27.03.2024
NO27.06.2024
Cited inInternational search[IY]WO0217944  (NATUMIN PHARMA AB [SE]);
 [YD]EP2135621  (FASANI ROBERTO [IT]);
 [YD]FR2964834  (COHEN MARC [FR]);
by applicantEP2135621
 FR2964834
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.